中國恆泰集團(02011.HK)2021年淨虧收窄62.7%至1750.3萬港元
格隆匯3月31日丨中國恆泰集團(02011.HK)公佈2021年度未經審核業績,期內集團實現收入2.40億港元,同比增長40.9%;毛利7191.3萬港元,同比增長110.1%;權益股東應占虧損1750.3萬港元,同比收窄62.7%;每股基本虧損3.8港仙,不派息。
截至2021年12月31日止年度,銷售條裝拉鍊及拉頭收入增加約6765萬港元或40.4%至約2.35億港元(2020年:約1.67億港元)。增加主要由於全球(尤其是中國)經濟企穩及全球COVID-19疫情影響逐漸平復,導致本集團客户(主要為生產服裝產品的OEM)的銷售訂單數量增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.